|
Parameter
|
CKD (n = 40)
|
CAPD (n = 40)
|
HD (n = 40)
|
Controls (n = 41)
|
|---|
|
Age
|
41.0 (36.0–51.5)
|
39.5 (35.0–46.5)
|
40.5 (36.0–49.0)
|
41.0 (29.0–48.0)
|
|
DOD (years)
| |
3.0 (1.5–4.0)
|
3.0 (2.0–6.5)
| |
|
Gender (n/%)
|
|
Female
|
20 (50.0)
|
19 (47.5)
|
18 (45.0)
|
23 (56.1)
|
|
Male
|
20 (50.0)
|
21 (52.5)
|
22 (55.0)
|
18 (43.9)
|
|
BMI
|
|
< 30 kg/m2
|
19 (47.5)
|
31 (77.5)
|
32 (80.0)
|
25 (61.0)
|
|
> 30 kg/m2
|
21 (52.5)
|
9 (22.5)
|
8 (20.0)
|
16 (39.0)
|
|
WHR
|
|
Normal
|
12 (30.0)
|
9 (22.5)
|
15 (37.5)
|
28 (68.3)
|
|
Increased
|
28 (70.0)
|
31 (72.5)
|
25 (62.5)
|
13 (31.7)
|
|
Hypertensiona
|
|
Absent
|
15 (37.5)
|
12 (30)
|
17 (17.5)
|
34 (82.9)
|
|
Present
|
25 (62.5)
|
28 (70)
|
33 (82.5)
|
7 (17.1)
|
|
SCr (μmol/l)
|
124 (106–166)
|
1175 (878–1345)
|
513 (405–712
|
80 (63–89)
|
|
Albumin (g/l)
|
41.5 (38.5–44.0)
|
35.5 (33.0–40.0)
|
38.5 (35.0–41.0)
|
44.0 (42.0–45.0)
|
|
TC (mmol/l)
|
|
< 5.17
|
31 (77.5)
|
19 (47.5)
|
40 (100)
|
36 (87.8)
|
|
> 5.17
|
9 (22.5)
|
21 (52.5)
|
0
|
5 (12.2)
|
|
LDL
|
|
< 2.59
|
19 (47.5)
|
14 (35.0)
|
36 (90.0)
|
21 (51.2)
|
|
> 2.59
|
21 (52.5)
|
26 (65.0)
|
4 (10.0)
|
20 (48.8)
|
|
HDLb
|
|
Low
|
30 (75.0)
|
21 (52.5)
|
15 (37.5)
|
23 (56.1)
|
|
Normal
|
10 (25.0)
|
19 (47.5)
|
25 (62.5)
|
18 (43.9)
|
|
SU (n/%)
|
|
Yes
|
7 (17.5)
|
14 (35.0)
|
7 (17.5)
| |
|
No
|
33 (82.5)
|
26 (65.0)
|
33 (82.5)
| |
|
AAU (n/%)
|
|
Yes
|
7 (17.5)
|
11 (27.5)
|
8 (20.0)
| |
|
No
|
33 (82.5)
|
29 (72.5)
|
32 (80.0)
| |
|
PBU (n/%)
|
|
Yes
|
2 (5.0)
|
32 (80.0)
|
32 (80.0)
| |
|
No
|
38 (95.0)
|
8 (20.0)
|
8 (20.0)
| |
|
AsVD (n/%)
|
|
Absent
|
21 (52.5)
|
12 (30.0)
|
21 (52.5)
|
34 (82.9)
|
|
Present
|
19 (47.5)
|
28 (70.0)
|
19 (47.5)
|
7 (17.1)
|
- CKD Chronic kidney disease, PD Peritoneal dialysis, HD Haemodialysis, DOD Duration on dialysis, BMI Body mass index, WHR Waist-hip ratio, TC Total cholesterol, LDL-C Low density cholesterol, HDL-C High density cholesterol, SU Statin use, AAU ACE-I / ARB (angiotensin converting enzyme / angiotensin receptor blocker) use, PBU Phosphate binder use (calcium carbonate), AsVD Atherosclerotic vascular disease; aSystolic blood pressure > 140 mmHg ± diastolic blood pressure > 90 mmHg, Low HDL-C = < 1.03 in male and < 1.29 mmol/l in female
